Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural Life's earnings per share without non-recurring items for the
six
months ended in Sep. 2025 was $-0.27.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was $7.78.
During the past 12 months, Bon Natural Life's average earnings per share (NRI) Growth Rate was -118.50% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Bon Natural Life's EPS without NRI or its related term are showing as below:
During the past 8 years, Bon Natural Life's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 195.40% per year. The lowest was -71.10% per year. And the median was 21.40% per year.
BON's 3-Year EPS without NRI Growth Rate is not ranked *
in the Chemicals industry.
Industry Median: -1.7 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
Bon Natural Life's EPS (Diluted) for the
six
months ended in Sep. 2025 was $-0.27.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $12.23.
Bon Natural Life's EPS (Basic) for the
six
months ended in Sep. 2025 was $-0.27.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was $13.73.
Bon Natural Life (NAS:BON) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Bon Natural Life EPS without NRI Related Terms
Bon Natural Life EPS without NRI Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BON vs SNES, YMAT, GLGI: EPS without NRI Comparison
For the Specialty Chemicals subindustry, Bon Natural Life's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life PE Ratio without NRI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $7.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bon Natural Life (BON) has a EPS without NRI of $7.78 as of Sep. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bon Natural Life and its competitors. According to the industry distribution chart, Bon Natural Life ranks #999999 out of 1257 companies in the Chemicals industry.
Is Bon Natural Life's EPS without NRI too high?
Bon Natural Life's current EPS without NRI is $7.78. Based on the distribution chart, Bon Natural Life ranks #999999 out of 1257 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's EPS without NRI compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #999999 out of 1257 companies for EPS without NRI. This places Bon Natural Life in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bon Natural Life and its competitors. Bon Natural Life's current EPS without NRI is $7.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.14 — trading 50% above its estimated fair value. The current EPS without NRI is $7.78. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Bon Natural Life (BON), the current EPS without NRI is $7.78 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 50% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
EPS without NRI: $7.78
GF Value™: $0.76 vs. price of $1.14 (50% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
